Pau D´arco Bark Powder
Pau D´arco Bark Dry Extract 4:1
Pau D'Arco Products
Pau D´Arco = Lapacho = Taheebo Bark (Tabebuia Avellanedae Lor.)
(Choose below the products your interest, quantity of each one, tell us the destination airport and send us by e-mail/form; as soon we will revert you with our best prices)
1 – Pau D´arco (lapacho = taheebo) Bark Powder
Packing: 25kg net polypropylene bags into fiber barrel
2 – Pau D´arco (lapacho = taheebo) Dry Extract 4:1 (spray dried)
Packing: 25kg net polypropylene bags into fiber barrel
Scientific Name: Tabebuia avellanedae Lor.
Synonyms: Tabebuia avellanedae, T. ipe, T. nicaraguensis, T. schunkeuigoi, T. serratifolia, T. altissima, T. palmeri, Gelseminum avellanedae, Handroanthus avellanedae, H. impetiginosus, Tecoma adenophylla, Tecoma avellanedae, Tecoma eximia, Tecoma impetiginosa, Tecoma integra, Tecoma ipe
• kills bacteria
• kills fungi
• kills leukemia cells
• kills viruses
• relieves pain
• reduces inflammation
• kills parasites
• fights free radicals
• reduces tumors
• thins blood
• enhances immunity
• mildly laxative
• relieves rheumatism
• dries secretions
Pau d’arco is a large tree that grows naturally in the rainforests of Central and South America. It may be cultivated in southern Florida. There are about 100 species of the tree, which produces large flowers and can grow to 150 feet tall and 6 feet in diameter. The inner bark of the tree is used in herbal remedies.
Laboratory and animal studies suggest that lapachol and other compounds extracted from or made from pau d’arco may have some effects against certain illnesses. At this time, available evidence from well-designed, controlled studies does not support this substance as an effective treatment for cancer in humans. Pau d’arco also has potentially dangerous side effects.
How is it promoted for use?
Pau d’arco is promoted as a cure for dozens of illnesses and medical conditions, including arthritis, ulcers, diabetes, and cancer. Proponents also claim that, when taken internally, pau d’arco relieves infections, reduces inflammation, promotes digestion, strengthens the immune system, flushes toxins from the body, and protects against cardiovascular disease and high blood pressure. Proponents also use it to treat lupus, osteomyelitis, Parkinson’s disease, psoriasis, and to relieve pain. Some use the boiled bark externally as a poultice or use the strained liquid as a wash to treat skin inflammations, fungal infections, hemorrhoids, eczema, and wounds.
What does it involve?
Pau d’arco is available as a capsule, tablet, salve, liquid extract, powder, and tea from health food stores, many drugstores, and Internet sources. Recommended dosage varies by manufacturer. When making tea, practitioners say the bark must be boiled or simmered for at least 8-10 minutes to release the active ingredients, which do not dissolve easily in water.
What is the history behind it?
Tea made from pau d’arco is thought to have been used by the ancient Incas and natives of the South American rain forests, who took it to cure disease and as a tonic to strengthen the body and improve overall health. Caribbean folk healers reportedly use the leaf and the bark to treat backaches, toothaches, and sexually transmitted diseases. The native tribes of Brazil used the tree to make bows for hunting. When the Portuguese colonized Brazil, they named the tree pau d’arco, which means "bow stick." The herb remains a popular Brazilian folk remedy.
New interest in pau d’arco arose in the mid-1960s, when a Brazilian physician claimed that the substance could relieve pain, increase the number of red blood cells, and cure numerous illnesses, including cancer. The NCI sponsored a study of lapachol (an extract of pau d’arco) in humans, but studies stopped when it was understood that the amount required to affect tumors also interfered with blood clotting. The new drug application for lapachol was closed out in 1970. It was no longer pursued as a cancer treatment agent, although a few studies have been done since. Canada banned the substance in 1985.
Since the early 1980s, health food stores in the United States have sold pau d’arco, which is promoted as a treatment for many kinds of medical complaints. As of 2012, Brazil has listed the pau d’arco tree as endangered; which might limit availability of the tree bark.
What is the evidence?
One of the active ingredients in pau d’arco that has been studied is called lapachol. In laboratory animals, lapachol was found to act against malaria and certain kinds of animal tumor cells, such as sarcoma, but it did not have an effect against other kinds of cancer, including leukemia and adenocarcinoma. Some studies in rodents have also shown that higher doses of lapachol can promote cancer metastasis (spread), as well as cause changes in DNA that might promote cancer. Further studies would be required to determine whether these results apply to humans.
There have only been a few studies on lapachol in humans. An uncontrolled study sponsored by the National Cancer Institute in the early 1970s found no toxic effects on liver or kidney tissue. However, lapachol did prevent blood from clotting, and doses thought to be high enough to affect tumors posed a serious risk of bleeding. Clotting function returned to normal after the drug was stopped.
Beta-lapachone is another compound from pau d’arco that is being studied at as a possible cancer treatment. These studies have been done in the lab, rather than in humans, but so far they show some effect on cancer cells growing in a dish. Studies in humans will be needed to find out if beta-lapachone can actually slow cancer growth.
Unconfirmed tests showed that the tree bark stimulated immune system cells called macrophages into action. The substance also killed lung cancer cells and liver cancer cells grown in test tubes and reduced the rate of lung cancer spread in mice after surgery to remove the cancerous tumor. The bark extract also may kill bacteria or fungi.
Pau d’arco contains at least 20 active compounds, such as naphthaquinones (of which lapachol is one), anthroquinones, quercetin, and other flavonoids with effects that are not fully known. In a 2004 study, 2 compounds made from naphthaquinones showed promise in animal studies for malaria treatment. It is important to note, however, that studies of purified extracted compounds would not be expected to yield the same results as studies of the raw bark, which contains a number of compounds in varying amounts.
Are there any possible problems or complications?
This product is sold as a dietary supplement in the United States. Unlike companies that produce drugs (which must be tested before being sold), the companies that make supplements are not required to prove to the Food and Drug Administration that their supplements are safe or effective, as long as they don't claim the supplements can prevent, treat, or cure any specific disease.
Some such products may not contain the amount of the herb or substance that is on the label, and some may include other substances (contaminants). Actual amounts per dose may vary between brands or even between different batches of the same brand. In 2007, the FDA wrote new rules to improve the quality of manufacturing for dietary supplements and the proper listing of supplement ingredients. But these rules do not address the safety of the ingredients or their effects on health.
Most such supplements have not been tested to find out if they interact with medicines, foods, or other herbs and supplements. Even though some reports of interactions and harmful effects may be published, full studies of interactions and effects are not often available. Because of these limitations, any information on ill effects and interactions below should be considered incomplete.
Pau d’arco has some potentially serious side effects. Some of the chemicals in pau d’arco, such as hydroquinone, are known to be toxic. High doses taken internally may cause liver and kidney damage. In animal studies, birth defects and deaths occurred among rats whose mothers were given lapachol during pregnancy. Pau d’arco should be avoided, especially by women who are pregnant or breastfeeding.
Even fairly low doses of pau d’arco can cause dizziness, nausea, vomiting, and diarrhea and can interfere with blood clotting. The resulting bleeding can cause anemia. In addition, pau d’arco, when taken by mouth, can interact with aspirin and blood-thinning drugs, further increasing the risk of bleeding. It may also increase the risk of bleeding in people with hemophilia or other clotting disorders. It caused some DNA mutations in rodents; and caused lighter-weight seminal vesicles (semen producing glands) in adult male rats, but it is not clear if it would have the same effects in humans.
The bark of the tree can sensitize skin and has caused asthma in work settings where people are exposed to the wood dust. Allergic reactions are possible.
Twelve commercial pau d’arco products that were tested in Canada showed that only one contained lapachol, which normally makes up about 7 percent of pau d’arco, suggesting the products likely contained other substances. Concerns persist that unrelated types of wood bark with similar colors are being substituted and sold as pau d’arco. It is very difficult to be sure what types of trees are included, since there are other trees from South America that look like pau d’arco but are not chemically similar.
The potential interactions between pau d'arco and other drugs and herbs should be considered. Some of these combinations may be dangerous. Always tell your doctor and pharmacist about any herbs you are taking.
Relying on this type of treatment alone and avoiding or delaying conventional medical care for cancer may have serious health consequences.
Algranti E, Mendonca EM, Ali SA, Kokron CM, Raile V. Occupational asthma caused by Ipe (Tabebuia spp) dust. J Investig Allergol Clin Immunol. 2005;15:81-83.
Amaral D, Vieira I, Salomão R, et al. The status of conservation of urban forests in eastern Amazonia. Braz J Biol.2012 May;72(2):257-65.
American Cancer Society. Questionable methods of cancer management: ‘nutritional’ therapies. CA Cancer J Clin. 1993;43:309-319. Available online at http://onlinelibrary.wiley.com/doi/10.3322/canjcli...
Awang DVC. Commercial Taheebo Lacks Active Ingredient. Can. Pharm. J. 1988;121(5):323-326.
BC Cancer Agency Web site. Pau d’arco/taheebo tea/lapacho/lapacho morado/ipe roxo/ipe/trumpet bush. Accessed atwww.bccancer.bc.ca/HPI/UnconventionalTherapies/Pau... on June 6, 2008. Content no longer available.
Cassileth BR. Evaluating complementary and alternative therapies for cancer patients. CA Cancer J Clin. 1999;49:362-375.
de Andrade-Neto VF, Goulart MO, da Silva Filho JF, et al. Antimalarial activity of phenazines from lapachol, beta-lapachone and its derivatives against Plasmodium falciparum in vitro and Plasmodium berghei in vivo. Bioorg Med Chem Lett. 2004;14:1145-1149.
de Cássia da Silveira E Sá R, de Oliveira Guerra M. Reproductive toxicity of lapachol in adult male Wistar rats submitted to short-term treatment. Phytother Res. 2007 Jul;21(7):658-662.
Dinnen RD, Ebisuzaki K. The search for novel anticancer agents: a differentiation-based assay and analysis of a folklore product. Anticancer Res. 1997;17:1027-1033.
Drug Digest Web site. Pau D’arco. Accessed at www.drugdigest.org/ on July 27, 2012.
Felício AC, Chang CV, Brandão MA, Peters VM, Guerra Mde O. Fetal growth in rats treated with lapachol.Contraception. 2002;66:289-293.
Fetrow CW, Avila JR. Professional's Handbook of Complementary & Alternative Medicines. Philadelphia, PA: Lippincott Williams & Wilkins; 2004.
Gómez Castellanos JR, Prieto JM, Heinrich M. Red Lapacho (Tabebuia impetiginosa)--a global ethnopharmacological commodity? J Ethnopharmacol. 2009 Jan 12;121(1):1-13.
Maeda M, Murakami M, Takegami T, Ota T. Promotion or suppression of experimental metastasis of B16 melanoma cells after oral administration of lapachol. Toxicol Appl Pharmacol. 2008 Jun 1;229(2):232-238.
Maistro EL, Fernandes DM, Pereira FM, Andrade SF. Lapachol induces clastogenic effects in rats. Planta Med. 2010 Jun;76(9):858-862.
Memorial Sloan-Kettering Cancer Center Web site. Pau D’arco. Accessed at http://www.mskcc.org/cancer-care/herb/pau-d-arco on July 27, 2012.
Montbriand MJ. Past and present herbs used to treat cancer: medicine, magic, or poison? Oncol Nurs Forum. 1999;26:49-60; quiz 61-62.
US Congress, Office of Technology Assessment. Unconventional Cancer Treatments: OTA-H-405. Washington, DC: US Government Printing Office; 1990. Accessed online at http://www.cancertreatmentwatch.org/reports/ota.pd... on July 27, 2012.
Von der Pahlen MC. Pau d’arco (Tabebuia spp.). In Shanley P, Pierce AR, Laird SA, Guillen A (eds), Tapping the Green Market: Certification and Management of Non-Timber Forest Products. Earthscan, Sterling, Va. 2002, 89-90.
Woo HJ, Choi YH. Growth inhibition of A549 human lung carcinoma cells by beta-lapachone through induction of apoptosis and inhibition of telomerase activity. Int J Oncol. 2005;26:1017-1023.
Woo HJ, Park KY, Rhu CH, et al. Beta-lapachone, a quinone isolated from Tabebuia avellanedae, induces apoptosis in HepG2 hepatoma cell line through induction of Bax and activation of caspase. J Med Food. 2006;9:161-168.
Note: This information may not cover all possible claims, uses, actions, precautions, side effects or interactions. It is not intended as medical advice, and should not be relied upon as a substitute for consultation with your doctor, who is familiar with your medical situation.